Roadside Drug Testing: A New Zealand Initiative
Starting tomorrow, New Zealand introduces a groundbreaking initiative: roadside drug testing for drivers. This move aims to enhance road safety by detecting drivers under the influence of impairing drugs. Here's a comprehensive breakdown of how it will work and the key considerations.
The Testing Process:
- Initial Test: Drivers will be asked to swipe their tongue on an oral-fluid screening device, testing for four substances: THC (cannabis), methamphetamine, MDMA (ecstasy), and cocaine. This test takes approximately 10 minutes.
- Follow-up Tests: If the initial test is positive, two more tests will be conducted. The second test is identical to the first, and if it's also positive, the driver is prohibited from driving for 12 hours. If the second test is negative, the driver is free to go after the third test.
- Third Test: Drivers must provide a saliva sample, which is then sent for laboratory analysis. This test checks for 25 drugs.
Refusing Testing:
- Drivers cannot use prescriptions or medical notes to avoid testing. Refusing the roadside drug test can result in an infringement notice, including a $400 fine, 75 demerit points, and a 12-hour driving ban.
Medical Defence:
- If an infringement notice is issued after laboratory testing, drivers can apply for medical defence if the positive result is due to a prescribed drug. However, this application can only be made after the third test's results are available.
Concerns and Considerations:
- Prescription Medicines: Critics argue that the test may return positive results for prescription medicines, raising concerns about consistency with the Bill of Rights Act.
- False Positives: There are worries that the test might generate positive results long after drugs would impair driving ability, leading to potential false positives.
- Time and Driving Restrictions: The time required for testing and waiting for results could pose challenges for drivers, especially if further testing leads to a 12-hour driving ban.
- Prescription Drug Use: Drivers using prescribed medicines are advised to consult their health practitioners and understand potential impairing effects. However, the ultimate responsibility lies with the driver.
Impact and Benefits:
- Road Safety: The initiative aims to reduce road fatalities caused by drug-impaired driving, with approximately 30% of such fatalities involving impairing drugs.
- Deterrence: Police believe the new tests will deter drug-driving and help catch those who do so.
Conclusion:
The introduction of roadside drug testing in New Zealand is a significant step towards safer roads. While concerns exist, the initiative's potential to reduce harm caused by drug-impaired driving is a compelling reason for its implementation. Drivers are encouraged to be aware of the testing process and the importance of road safety.
